Nanoscale platforms for messenger RNA delivery

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 11, Issue 2, 2019, Pages

  Li, Bin ^a   Zhang, Xinfu ^a   Dong, Yizhou ^a,b,c,d  

^a OHIO STATE UNIVERSITY   (United States)

^b The Ohio State University   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

delivery; messenger RNA; nanoparticles

Indexed keywords

BIOLOGY; CONTROLLED DRUG DELIVERY; DISEASES; NANOPARTICLES; NANOSTRUCTURED MATERIALS; PROTEINS; RNA; TARGETED DRUG DELIVERY;

BROAD APPLICATION; CANCER IMMUNOTHERAPY; DELIVERY; MESSENGER RNA; MESSENGER RNAS (MRNA); NANO-SCALE SYSTEM; THERAPEUTIC APPLICATION; THERAPEUTIC VACCINES;

NUCLEIC ACIDS;

MESSENGER RNA; NANOPARTICLE; POLYMER; PROTEIN DERIVATIVE; SOLID LIPID NANOPARTICLE; LIPID; PROTEIN;

CELL MIGRATION; HUMAN; NANOMEDICINE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PHARMACOKINETIC PARAMETERS; PRIORITY JOURNAL; REVIEW; ANIMAL; CHEMISTRY; GENE TRANSFER; GENETICS; METABOLISM; NANOTECHNOLOGY; PROCEDURES;

ANIMALS; GENE TRANSFER TECHNIQUES; HUMANS; LIPIDS; NANOPARTICLES; NANOTECHNOLOGY; PROTEINS; RNA, MESSENGER;

EID: 85046365539     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1530     Document Type: Review

References (126)

1. Aini, H., Itaka, K., Fujisawa, A., Uchida, H., Uchida, S., Fukushima, S., … Ohba, S. (2016). Messenger RNA delivery of a cartilage-anabolic transcription factor as a disease-modifying strategy for osteoarthritis treatment. Scientific Reports, 6, 18743
2. Akinc, A., Thomas, M., Klibanov, A. M., & Langer, R. (2005). Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. Journal of Gene Medicine, 7, 657–663
3. Akinc, A., Zumbuehl, A., Goldberg, M., Leshchiner, E. S., Busini, V., Hossain, N., … Anderson, D. G. (2008). A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nature Biotechnology, 26, 561–569
4. Alabi, C. A., Love, K. T., Sahay, G., Yin, H., Luly, K. M., Langer, R., & Anderson, D. G. (2013). Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery. Proceedings of the National Academy of Sciences of the United States of America, 110, 12881–12886
5. Badieyan, Z. S., Berezhanskyy, T., Utzinger, M., Aneja, M. K., Emrich, D., Erben, R., … Plank, C. (2016). Transcript-activated collagen matrix as sustained mRNA delivery system for bone regeneration. Journal of Controlled Release, 239, 137–148
6. Bire, S., Gosset, D., Jégot, G., Midoux, P., Pichon, C., & Rouleux-Bonnin, F. (2013). Exogenous mRNA delivery and bioavailability in gene transfer mediated by piggyBac transposition. BMC Biotechnology, 13, 75
7. Bogers, W. M., Oostermeijer, H., Mooij, P., Koopman, G., Verschoor, E. J., Davis, D., … Barnett, S. W. (2014). Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion. Journal of Infectious Diseases, 211, 947–955
8. Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. (1995). A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proceedings of the National Academy of Sciences of the United States of America, 92, 7297–7301
9. Brito, L. A., Kommareddy, S., Maione, D., Uematsu, Y., Giovani, C., Berlanda Scorza, F., … Geall, A. J. (2015). Self-amplifying mRNA vaccines. Advances in Genetics, 89, 179–233
10. Chahal, J. S., Fang, T., Woodham, A. W., Khan, O. F., Ling, J., Anderson, D. G., & Ploegh, H. L. (2017). An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse model. Scientific Reports, 7, 252
11. Chahal, J. S., Khan, O. F., Cooper, C. L., McPartlan, J. S., Tsosie, J. K., Tilley, L. D., … Anderson, D. G. (2016). Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and toxoplasma gondii challenges with a single dose. Proceedings of the National Academy of Sciences, 113, E4133–E4142
12. Chan, K. P., Chao, S. H., & Kah, J. C. Y. (2018). Universal mRNA translation enhancement with gold nanoparticles conjugated to oligonucleotides with a poly(T) sequence. ACS Applied Materials & Interfaces, 10, 5203–5212
13. Chan, K. P., Gao, Y., Goh, J. X., Susanti, D., Yeo, E. L., Chao, S. H., & Kah, J. C. (2017). Exploiting the protein corona from cell lysate on DNA functionalized gold nanoparticles for enhanced mRNA translation. ACS Applied Materials & Interfaces, 9, 10408–10417
14. Chen, C. Y. A., Ezzeddine, N., & Shyu, A. B. (2008). Messenger RNA half-life measurements in mammalian cells. Methods in Enzymology, 448, 335–357
15. Chen, Q., Qi, R., Chen, X., Yang, X., Wu, S., Xiao, H., & Dong, W. (2017). A targeted and stable polymeric nanoformulation enhances systemic delivery of mRNA to tumors. Molecular Therapy, 25, 92–101
16. Cheng, C., Convertine, A. J., Stayton, P. S., & Bryers, J. D. (2012). Multifunctional triblock copolymers for intracellular messenger RNA delivery. Biomaterials, 33, 6868–6876
17. Cheng, X., & Lee, R. J. (2016). The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery. Advanced Drug Delivery Reviews, 99, 129–137
18. Chiper, M., Tounsi, N., Kole, R., Kichler, A., & Zuber, G. (2017). Self-aggregating 1.8 kDa polyethylenimines with dissolution switch at endosomal acidic pH are delivery carriers for plasmid DNA, mRNA, siRNA and exon-skipping oligonucleotides. Journal of Controlled Release, 246, 60–70
19. Choi, H. Y., Lee, T. J., Yang, G. M., Oh, J., Won, J., Han, J., … Cho, S. G. (2016). Efficient mRNA delivery with graphene oxide-polyethylenimine for generation of footprint-free human induced pluripotent stem cells. Journal of Controlled Release, 235, 222–235
20. Colombani, T., Peuziat, P., Dallet, L., Haudebourg, T., Mevel, M., Berchel, M., … Pitard, B. (2017). Self-assembling complexes between binary mixtures of lipids with different linkers and nucleic acids promote universal mRNA, DNA and siRNA delivery. Journal of Controlled Release, 249, 131–142
21. Colosimo, A., Serafino, A., Sangiuolo, F., Di Sario, S., Bruscia, E., Amicucci, P., … Mossa, G. (1999). Gene transfection efficiency of tracheal epithelial cells by DC-chol-DOPE/DNA complexes. Biochimica et Biophysica Acta, 1419, 186–194
22. Crowley, S. T., Poliskey, J. A., Baumhover, N. J., & Rice, K. G. (2015). Efficient expression of stabilized mRNA PEG-peptide polyplexes in liver. Gene Therapy, 22, 993–999
23. Cullis, P. R., & Hope, M. J. (2017). Lipid nanoparticle systems for enabling gene therapies. Molecular Therapy, 25, 1467–1475
24. Demoulins, T., Milona, P., Englezou, P. C., Ebensen, T., Schulze, K., Suter, R., … KC, M. C. (2016). Polyethylenimine-based polyplex delivery of self-replicating RNA vaccines. Nanomedicine, 12, 711–722
25. DeRosa, F., Guild, B., Karve, S., Smith, L., Love, K., Dorkin, J. R., … Heartlein, M. W. (2016). Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system. Gene Therapy, 23, 699–707
26. Devoldere, J., Dewitte, H., De Smedt, S. C., & Remaut, K. (2016). Evading innate immunity in nonviral mRNA delivery: Don't shoot the messenger. Drug Discovery Today, 21, 11–25
27. Dharmalingam, P., Rachamalla, H. K. R., Lohchania, B., Bandlamudi, B., Thangavel, S., Murugesan, M. K., … Marepally, S. (2017). Green transfection: Cationic lipid nanocarrier system derivatized from vegetable fat, palmstearin enhances nucleic acid transfections. ACS Omega, 2, 7892–7903
28. Dimitriadis, G. J. (1978). Translation of rabbit globin mRNA introduced by liposomes into mouse lymphocytes. Nature, 274, 923–924
29. Dong, Y., Dorkin, J. R., Wang, W., Chang, P. H., Webber, M. J., Tang, B. C., … Anderson, D. G. (2016). Poly(glycoamidoamine) brushes formulated nanomaterials for systemic siRNA and mRNA delivery in vivo. Nano Letters, 16, 842–848
30. Dong, Y., Eltoukhy, A. A., Alabi, C. A., Khan, O. F., Veiseh, O., Dorkin, J. R., … Anderson, D. G. (2014). Lipid-like nanomaterials for simultaneous gene expression and silencing in vivo. Advanced Healthcare Materials, 3, 1392–1397
31. Dong, Y., Love, K. T., Dorkin, J. R., Sirirungruang, S., Zhang, Y., Chen, D., … Anderson, D. G. (2014). Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates. Proceedings of the National Academy of Sciences of the United States of America, 111, 3955–3960
32. Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., … Danielsen, M. (1987). Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proceedings of the National Academy of Sciences of the United States of America, 84, 4713–4717
33. Fenton, O. S., Kauffman, K. J., Kaczmarek, J. C., McClellan, R. L., Jhunjhunwala, S., Tibbitt, M. W., … Anderson, D. G. (2017). Synthesis and biological evaluation of ionizable lipid materials for the in vivo delivery of messenger RNA to b lymphocytes. Advanced Materials, 29, 1606944
34. Fenton, O. S., Kauffman, K. J., McClellan, R. L., Appel, E. A., Dorkin, J. R., Tibbitt, M. W., … Anderson, D. G. (2016). Bioinspired alkenyl amino alcohol ionizable lipid materials for highly potent in vivo mRNA delivery. Advanced Materials, 28, 2939–2943
35. Finn, J. D., Smith, A. R., Patel, M. C., Shaw, L., Youniss, M. R., van Heteren, J., … Morrissey, D. V. (2018). A single administration of CRISPR/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing. Cell Reports, 22, 2227–2235
36. Geall, A. J., Verma, A., Otten, G. R., Shaw, C. A., Hekele, A., Banerjee, K., et al. (2012). Nonviral delivery of self-amplifying RNA vaccines. Proceedings of the National Academy of Sciences of the United States of America, 104, 14604–14609
37. Gilboa, E., & Vieweg, J. (2004). Cancer immunotherapy with mRNA-transfected dendritic cells. Immunological Reviews, 199, 251–263
38. Grabbe, S., Haas, H., Diken, M., Kranz, L. M., Langguth, P., & Sahin, U. (2016). Translating nanoparticulate-personalized cancer vaccines into clinical applications: Case study with RNA-lipoplexes for the treatment of melanoma. Nanomedicine (London, England), 11, 2723–2734
39. Granot, Y., & Peer, D. (2017). Delivering the right message: Challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics—An innate immune system standpoint. Seminars in Immunology, 34, 68–77
40. Guan, S., & Rosenecker, J. (2017). Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems. Gene Therapy, 24, 133–143
41. Habrant, D., Peuziat, P., Colombani, T., Dallet, L., Gehin, J., Goudeau, E., … Pitard, B. (2016). Design of ionizable lipids to overcome the limiting step of endosomal escape: Application in the intracellular delivery of mRNA, DNA, and siRNA. Journal of Medicinal Chemistry, 59, 3046–3062
42. Hajj, K. A., & Whitehead, K. A. (2017). Tools for translation: Non-viral materials for therapeutic mRNA delivery. Nature Reviews Materials, 2, 17056
43. Hecker, J. G. (2016). Non-viral, lipid-mediated DNA and mRNA gene therapy of the central nervous system (CNS): Chemical-based transfection. Methods in Molecular Biology, 1382, 307–324
44. Hoerr, I., Obst, R., Rammensee, H. G., & Jung, G. (2000). In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies. European Journal of Immunology, 30, 1–7
45. Huang, C. L., Leblond, A. L., Turner, E. C., Kumar, A. H., Martin, K., Whelan, D., … Caplice, N. M. (2015). Synthetic chemically modified mRNA-based delivery of cytoprotective factor promotes early cardiomyocyte survival post-acute myocardial infarction. Molecular Pharmaceutics, 12, 991–996
46. Islam, M. A., Reesor, E. K., Xu, Y., Zope, H. R., Zetter, B. R., & Shi, J. (2015). Biomaterials for mRNA delivery. Biomaterials Science, 3, 1519–1533
47. Jarzebinska, A., Pasewald, T., Lambrecht, J., Mykhaylyk, O., Kummerling, L., Beck, P., … Dohmen, C. (2016). A single methylene group in oligoalkylamine-based cationic polymers and lipids promotes enhanced mRNA delivery. Angewandte Chemie, 55, 9591–9595
48. Jekhmane, S., de Haas, R., Paulino da Silva Filho, O., van Asbeck, A. H., Favretto, M. E., Hernandez Garcia, A., … de Vries, R. (2017). Virus-like particles of mRNA with artificial minimal coat proteins: Particle formation, stability, and transfection efficiency. Nucleic Acid Therapeutics, 27, 159–167
49. Jiang, C., Mei, M., Li, B., Zhu, X., Zu, W., Tian, Y., … Tan, X. (2017). A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo. Cell Research, 27, 440–443
50. Kaczmarek, J. C., Patel, A. K., Kauffman, K. J., Fenton, O. S., Webber, M. J., Heartlein, M. W., … Anderson, D. G. (2016). Polymer-lipid nanoparticles for systemic delivery of mRNA to the lungs. Angewandte Chemie, 55, 13808–13812
51. Karikó, K., Muramatsu, H., Ludwig, J., & Weissman, D. (2011). Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA. Nucleic Acids Research, 39, e142
52. Kauffman, K. J., Dorkin, J. R., Yang, J. H., Heartlein, M. W., DeRosa, F., Mir, F. F., … Anderson, D. G. (2015). Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs. Nano Letters, 15, 7300–7306
53. Kauffman, K. J., Webber, M. J., & Anderson, D. G. (2016). Materials for non-viral intracellular delivery of messenger RNA therapeutics. Journal of Controlled Release, 240, 227–234
54. Kedmi, R., Ben-Arie, N., & Peer, D. (2010). The systemic toxicity of positively charged lipid nanoparticles and the role of toll-like receptor 4 in immune activation. Biomaterials, 31, 6867–6875
55. Kim, H., Park, Y., & Lee, J. B. (2015). Self-assembled messenger RNA nanoparticles (mRNA-NPs) for efficient gene expression. Scientific Reports, 5, 12737
56. Kolate, A., Baradia, D., Patil, S., Vhora, I., Kore, G., & Misra, A. (2014). PEG—a versatile conjugating ligand for drugs and drug delivery systems. Journal of Controlled Release, 192, 67–81
57. Kranz, L. M., Diken, M., Haas, H., Kreiter, S., Loquai, C., Reuter, K. C., … Sahin, U. (2016). Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature, 534, 396–401
58. Lallana, E., Rios de la Rosa, J. M., Tirella, A., Pelliccia, M., Gennari, A., Stratford, I. J., … Tirelli, N. (2017). Chitosan/hyaluronic acid nanoparticles: Rational design revisited for RNA delivery. Molecular Pharmaceutics, 14, 2422–2436
59. Lee, K., Yu, P., Lingampalli, N., Kim, H. J., Tang, R., & Murthy, N. (2015). Peptide-enhanced mRNA transfection in cultured mouse cardiac fibroblasts and direct reprogramming towards cardiomyocyte-like cells. International Journal of Nanomedicine, 10, 1841–1854
60. Li, B., & Dong, Y. (2017). Preparation and optimization of lipid-like nanoparticles for mRNA delivery. Methods in Molecular Biology, 1632, 207–217
61. Li, B., Luo, X., Deng, B., Giancola, J. B., McComb, D. W., Schmittgen, T. D., & Dong, Y. (2016). Effects of local structural transformation of lipid-like compounds on delivery of messenger RNA. Scientific Reports, 6, 22137
62. Li, B., Luo, X., Deng, B., Wang, J., McComb, D. W., Shi, Y., … Dong, Y. (2015). An orthogonal array optimization of lipid-like nanoparticles for mRNA delivery in vivo. Nano Letters, 15, 8099–8107
63. Li, B., Luo, X., & Dong, Y. (2016). Effects of chemically modified messenger RNA on protein expression. Bioconjugate Chemistry, 27, 849–853
64. Li, J., He, Y., Wang, W., Wu, C., Hong, C., & Hammond, P. T. (2017). Polyamine-mediated stoichiometric assembly of ribonucleoproteins for enhanced mRNA delivery. Angewandte Chemie, 56, 13709–13712
65. Li, J., Sun, Y., Jia, T., Zhang, R., Zhang, K., & Wang, L. (2014). Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer. International Journal of Cancer, 134, 1683–1694
66. Li, J., Wang, W., He, Y., Li, Y., Yan, E. Z., Zhang, K., … Hammond, P. T. (2017). Structurally programmed assembly of translation initiation nanoplex for superior mRNA delivery. ACS Nano, 11, 2531–2544
67. Li, M., Zhao, M., Fu, Y., Li, Y., Gong, T., Zhang, Z., & Sun, X. (2016). Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways. Journal of Controlled Release, 228, 9–19
68. Lin, Q., Chen, J., Zhang, Z., & Zheng, G. (2014). Lipid-based nanoparticles in the systemic delivery of siRNA. Nanomedicine, 9, 105–120
69. Ljungberg, K., & Liljeström, P. (2014). Self-replicating alphavirus RNA vaccines. Expert Review of Vaccines, 14, 177–194
70. Loomis, K. H., Kirschman, J. L., Bhosle, S., Bellamkonda, R. V., & Santangelo, P. J. (2016). Strategies for modulating innate immune activation and protein production of in vitro transcribed mRNAs. Journal of Materials Chemistry B, 4, 1619–1632
71. Love, K. T., Mahon, K. P., Levins, C. G., Whitehead, K. A., Querbes, W., Dorkin, J. R., … Anderson, D. G. (2010). Lipid-like materials for low-dose, in vivo gene silencing. Proceedings of the National Academy of Sciences, 107, 1864–1869
72. Luo, X., Li, B., Zhang, X., Zhao, W., Bratasz, A., Deng, B., … Dong, Y. (2017). Dual-functional lipid-like nanoparticles for delivery of mRNA and MRI contrast agents. Nanoscale, 9, 1575–1579
73. Malone, R. W., Felgner, P. L., & Verma, I. M. (1989). Cationic liposome-mediated RNA transfection. Proceedings of the National Academy of Sciences of the United States of America, 86, 6077–6081
74. Martinon, F., Krishnan, S., Lenzen, G., Magné, R., Gomard, E., Guillet, J. G., … Meulien, P. (1993). Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. European Journal of Immunology, 23, 1719–1722
75. Matsui, A., Uchida, S., Ishii, T., Itaka, K., & Kataoka, K. (2015). Messenger RNA-based therapeutics for the treatment of apoptosis-associated diseases. Scientific Reports, 5, 15810
76. McKinlaya, C. J., Vargas, J. R., Blake, T. R., Hardy, J. W., Kanada, M., Contag, C. H., … Waymouth, R. M. (2017). Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animals. Proceedings of the National Academy of Sciences of the United States of America, 114, E448–E456
77. Meng, Z., O'Keeffe-Ahern, J., Lyu, J., Pierucci, L., Zhou, D., & Wang, W. (2017). A new developing class of gene delivery: Messenger RNA-based therapeutics. Biomaterials Science, 5, 2381–2392
78. Michel, T., Luft, D., Abraham, M. K., Reinhardt, S., Salinas Medina, M. L., Kurz, J., … Krajewski, S. (2017). Cationic nanoliposomes meet mRNA: Efficient delivery of modified mRNA using hemocompatible and stable vectors for therapeutic applications. Molecular Therapy. Nucleic Acids, 8, 459–468
79. Midoux, P., & Pichon, C. (2015). Lipid-based mRNA vaccine delivery systems. Expert Review of Vaccines, 14, 221–234
80. Miller, J. B., Zhang, S., Kos, P., Xiong, H., Zhou, K., Perelman, S. S., … Siegwart, D. J. (2017). Non-viral CRISPR/Cas gene editing in vitro and in vivo enabled by synthetic nanoparticle co-delivery of cas9 mRNA and sgRNA. Angewandte Chemie, 56, 1059–1063
81. Nabhan, J. F., Wood, K. M., Rao, V. P., Morin, J., Bhamidipaty, S., LaBranche, T. P., … Guild, B. C. (2016). Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich's ataxia. Scientific Reports, 6, 20019
82. Nuhn, L., Kaps, L., Diken, M., Schuppan, D., & Zentel, R. (2016). Reductive decationizable block copolymers for stimuli-responsive mRNA delivery. Macromolecular Rapid Communications, 37, 924–933
83. Oberli, M. A., Reichmuth, A. M., Dorkin, J. R., Mitchell, M. J., Fenton, O. S., Jaklenec, A., … Blankschtein, D. (2017). Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy. Nano Letters, 17, 1326–1335
84. Palama, I. E., Cortese, B., D'Amone, S., & Gigli, G. (2015). mRNA delivery using non-viral PCL nanoparticles. Biomaterials Science, 3, 144–151
85. Pardi, N., Hogan, M. J., Pelc, R. S., Muramatsu, H., Andersen, H., DeMaso, C. R., … Weissman, D. (2017). Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature, 543, 248–251
86. Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018). mRNA vaccines—a new era in vaccinology. Nature Reviews. Drug Discovery, 17, 261–279
87. Pardi, N., Secreto, A. J., Shan, X., Debonera, F., Glover, J., Yi, Y., … Weissman, D. (2017). Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge. Nature Communications, 8, 14630
88. Pardi, N., Tuyishime, S., Muramatsu, H., Kariko, K., Mui, B. L., Tam, Y. K., … Weissman, D. (2015). Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. Journal of Controlled Release, 217, 345–351
89. Pascolo, S. (2017). Messenger RNA the inexpensive biopharmaceutical. Journal of Multidisciplinary Engineering Science and Technology, 4, 6937–6941
90. Patel, S., Ashwanikumar, N., Robinson, E., DuRoss, A., Sun, C., Murphy-Benenato, K. E., … Sahay, G. (2017). Boosting intracellular delivery of lipid nanoparticle-encapsulated mRNA. Nano Letters, 17, 5711–5718
91. Pisal, D. S., Kosloski, M. P., & Balu-Iyer, S. V. (2010). Delivery of therapeutic proteins. Journal of Pharmaceutical Sciences, 99, 2557–2575
92. Presnyak, V., Alhusaini, N., Chen, Y. H., Martin, S., Morris, N., Kline, N., … Coller, J. (2015). Codon optimality is a major determinant of mRNA stability. Cell, 160, 1111–1124
93. Ramaswamy, S., Tonnu, N., Tachikawa, K., Limphong, P., Vega, J. B., Karmali, P. P., … Verma, I. M. (2017). Systemic delivery of factor IX messenger RNA for protein replacement therapy. Proceedings of the National Academy of Sciences of the United States of America, 114, E1941–E1950
94. Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010). Endocytosis of nanomedicines. Journal of Controlled Release, 145, 182–195
95. Sahin, U., Kariko, K., & Tureci, O. (2014). mRNA-based therapeutics—developing a new class of drugs. Nature Reviews. Drug Discovery, 13, 759–780
96. Satyal, U., Draghici, B., Dragic, L. L., Zhang, Q., Norris, K. W., Madesh, M., … Ilies, M. A. (2017). Interfacially engineered pyridinium pseudogemini surfactants as versatile and efficient supramolecular delivery systems for DNA, siRNA, and mRNA. ACS Applied Materials & Interfaces, 9, 29481–29495
97. Scheel, B., Teufel, R., Probst, J., Carralot, J. P., Geginat, J., Radsak, M., … Pascolo, S. (2005). Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA. European Journal of Immunology, 35, 1557–1566
98. Schoenberg, D. R., & Maquat, L. E. (2012). Regulation of cytoplasmic mRNA decay. Nature Reviews. Genetics, 13, 246–259
99. Schrom, E., Huber, M., Aneja, M., Dohmen, C., Emrich, D., Geiger, J., … Kubisch-Dohmen, R. (2017). Translation of angiotensin-converting enzyme 2 upon liver- and lung-targeted delivery of optimized chemically modified mRNA. Molecular Therapy. Nucleic Acids, 7, 350–365
100. Sedic, M., Senn, J. J., Lynn, A., Laska, M., Smith, M., Platz, S. J., … Smith, P. F. (2017). Safety evaluation of lipid nanoparticle-formulated modified mRNA in the Sprague-Dawley rat and cynomolgus monkey. Veterinary Pathology, 55, 341–354
101. Sergeeva, O. V., Koteliansky, V. E., & Zatsepin, T. S. (2016). mRNA-based therapeutics—advances and perspectives. Biochemistry (Moscow), 81, 709–722
102. Sharp, P. A. (2009). The centrality of RNA. Cell, 136, 577–580
103. Sorgi, F. L., Bhattacharya, S., & Huang, L. (1997). Protamine sulfate enhances lipid-mediated gene transfer. Gene Therapy, 4, 961–968
104. Stanton, M. G., & Murphy-Benenato, K. E. (2017). Messenger RNA as a novel therapeutic approach. Topics in Medicinal Chemistry, 27, 237–253
105. Su, X., Fricke, J., Kavanagh, D. G., & Irvine, D. J. (2011). In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles. Molecular Pharmaceutics, 8, 774–787
106. Sun, Y., Sun, Y., Zhao, R., & Gao, K. (2016). Intracellular delivery of messenger RNA by recombinant PP7 virus-like particles carrying low molecular weight protamine. BMC Biotechnology, 16, 46
107. Turnbull, I. C., Eltoukhy, A. A., Fish, K. M., Nonnenmacher, M., Ishikawa, K., Chen, J., … Costa, K. D. (2016). Myocardial delivery of lipid nanoparticle carrying modRNA induces rapid and transient expression. Molecular Therapy, 24, 66–75
108. Uchida, H., Itaka, K., Uchida, S., Ishii, T., Suma, T., Miyata, K., … Kataoka, K. (2016). Synthetic polyamines to regulate mRNA translation through the preservative binding of eukaryotic initiation factor 4E to the cap structure. Journal of the American Chemical Society, 138, 1478–1481
109. Uchida, S., Kinoh, H., Ishii, T., Matsui, A., Tockary, T. A., Takeda, K. M., … Kataoka, K. (2016). Systemic delivery of messenger RNA for the treatment of pancreatic cancer using polyplex nanomicelles with a cholesterol moiety. Biomaterials, 82, 221–228
110. Udhayakumar, V. K., De Beuckelaer, A., McCaffrey, J., McCrudden, C. M., Kirschman, J. L., Vanover, D., … De Koker, S. (2017). Arginine-rich peptide-based mRNA nanocomplexes efficiently instigate cytotoxic t cell immunity dependent on the amphipathic organization of the peptide. Advanced Healthcare Materials, 6, 1601412
111. Ulmer, J. B., & Geall, A. J. (2016). Recent innovations in mRNA vaccines. Current Opinion in Immunology, 41, 18–22
112. Vallazza, B., Petri, S., Poleganov, M. A., Eberle, F., Kuhn, A. N., & Sahin, U. (2015). Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond. WIREs RNA, 6, 471–499
113. Verbeke, R., Lentacker, I., Wayteck, L., Breckpot, K., Van Bockstal, M., Descamps, B., … Dewitte, H. (2017). Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy: Restoring the immunogenicity of immunosilent mRNA. Journal of Controlled Release, 266, 287–300
114. Wang, H.-X., Li, M., Lee, C. M., Chakraborty, S., Kim, H.-W., Bao, G., & Leong, K. W. (2017). CRISPR/Cas9-based genome editing for disease modeling and therapy: Challenges and opportunities for nonviral delivery. Chemical Reviews, 117, 9874–9906
115. Wang, Y., Su, H. H., Yang, Y., Hu, Y., Zhang, L., Blancafort, P., & Huang, L. (2013). Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy. Molecular Therapy, 21, 358–367
116. Weide, B., Pascolo, S., Scheel, B., Derhovanessian, E., Pflugfelder, A., Eigentler, T. K., … Garbe, C. (2009). Direct injection of protamine-protected mRNA: Results of a phase 1/2 vaccination trial in metastatic melanoma patients. Journal of Immunotherapy, 32, 498–507
117. Weissman, D. (2015). mRNA transcript therapy. Expert Review of Vaccines, 14, 265–281
118. Whitehead, K. A., Dorkin, J. R., Vegas, A. J., Chang, P. H., Veiseh, O., Matthews, J., … Anderson, D. G. (2014). Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity. Nature Communications, 5, 4277
119. Yamamoto, A., Kormann, M., Rosenecker, J., & Rudolph, C. (2009). Current prospects for mRNA gene delivery. European Journal of Pharmaceutics and Biopharmaceutics, 71, 484–489
120. Yan, Y., Xiong, H., Zhang, X., Cheng, Q., & Siegwart, D. J. (2017). Systemic mRNA delivery to the lungs by functional polyester-based carriers. Biomacromolecules, 18, 4307–4315
121. Yeom, J. H., Ryou, S. M., Won, M., Park, M., Bae, J., & Lee, K. (2013). Inhibition of xenograft tumor growth by gold nanoparticle-DNA oligonucleotide conjugates-assisted delivery of BAX mRNA. PLoS One, 8, e75369
122. Yin, H., Song, C. Q., Dorkin, J. R., Zhu, L. J., Li, Y., Wu, Q., … Anderson, D. G. (2016). Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo. Nature Biotechnology, 34, 328–333
123. Yin, H., Song, C. Q., Suresh, S., Wu, Q., Walsh, S., Rhym, L. H., … Anderson, D. G. (2017). Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing. Nature Biotechnology, 35, 1179–1187
124. Zhang, X., Li, B., Luo, X., Zhao, W., Jiang, J., Zhang, C., … Dong, Y. (2017). Biodegradable amino-ester nanomaterials for Cas9 mRNA delivery in vitro and in vivo. ACS Applied Materials & Interfaces, 9, 25481–25487
125. Zhang, Y., Pelet, J. M., Heller, D. A., Dong, Y., Chen, D., Gu, Z., … Anderson, D. G. (2013). Lipid-modified aminoglycoside derivatives for in vivo siRNA delivery. Advanced Materials, 25, 4641–4645
126. Zhao, M., Li, M., Zhang, Z., Gong, T., & Sun, X. (2015). Induction of HIV-1 gag specific immune responses by cationic micelles mediated delivery of gag mRNA. Drug Delivery, 23, 2596–2607